Bioequivalence Study to Compare Dolutegravir 50mg Film-coated Tablets

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 3, 2024

Primary Completion Date

January 15, 2024

Study Completion Date

March 7, 2024

Conditions

HIV Infections

Interventions

DRUG

Dolutegravir 50 MG Film Coated Tablet

1 tablet of Dolutegravir 50mg film-coated tablets

DRUG

Tivicay 50mg, film-coated tablets

1 tablet of Dolutegravir 50mg film-coated tablets

Trial Locations (1)

ACDIMA Biocenter, Amman

All Listed Sponsors

lead

Humanis Saglık Anonim Sirketi

INDUSTRY

NCT06450275 - Bioequivalence Study to Compare Dolutegravir 50mg Film-coated Tablets | Biotech Hunter | Biotech Hunter